▶ 調査レポート

経口制御ドラッグデリバリーシステムの世界市場レポート2020

• 英文タイトル:Global Oral Controlled Drug Delivery System Sales Market Report 2020

が調査・発行した産業分析レポートです。経口制御ドラッグデリバリーシステムの世界市場レポート2020 / Global Oral Controlled Drug Delivery System Sales Market Report 2020 / MRC2102QY10114資料のイメージです。• レポートコード:MRC2102QY10114
• 出版社/出版日: / 2021年1月
• レポート形態:英文、PDF、144ページ
• 納品方法:Eメール(受注後2~3営業日)
• 産業分類:医療機器
• 販売価格(消費税別)
  Single User¥592,000 (USD4,000)▷ お問い合わせ
  Multi User¥888,000 (USD6,000)▷ お問い合わせ
  Enterprise License¥1,184,000 (USD8,000)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
QYリサーチ社の本調査レポートでは、世界の経口制御ドラッグデリバリーシステム市場について種類別(拡散制御放出システム、溶解制御放出システム、イオン交換樹脂制御放出、流体力学的バランス薬物送達システム、浸透圧制御放出システム、溶解・拡散制御放出システム)、用途別(病院、診療所、その他)、地域別(米国、ヨーロッパ、中国、日本、東南アジア、インド)に区分して調査し、纏めました。2015年~2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。
・経口制御ドラッグデリバリーシステム市場の概要
・世界の主要地域別経口制御ドラッグデリバリーシステム市場規模2015-2026
・主要プレイヤーの競争状況・市場シェア
・世界の経口制御ドラッグデリバリーシステム市場規模2015-2026:種類別(拡散制御放出システム、溶解制御放出システム、イオン交換樹脂制御放出、流体力学的バランス薬物送達システム、浸透圧制御放出システム、溶解・拡散制御放出システム)
・世界の経口制御ドラッグデリバリーシステム市場規模2015-2026:用途別(病院、診療所、その他)
・経口制御ドラッグデリバリーシステムの米国市場規模2015-2020
・経口制御ドラッグデリバリーシステムのヨーロッパ市場規模2015-2020
・経口制御ドラッグデリバリーシステムの中国市場規模2015-2020
・経口制御ドラッグデリバリーシステムの日本市場規模2015-2020
・経口制御ドラッグデリバリーシステムの東南アジア市場規模2015-2020
・経口制御ドラッグデリバリーシステムのインド市場規模2015-2020
・主要プレイヤーの企業情報:事業概要・売上・企業動向
・経口制御ドラッグデリバリーシステムの製造コスト分析
・販売チャネル、流通業者、顧客
・経口制御ドラッグデリバリーシステムの市場動向・機会・課題
・調査の結論

Market Analysis and Insights: Global Oral Controlled Drug Delivery System Market
The global Oral Controlled Drug Delivery System market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026.

Global Oral Controlled Drug Delivery System Scope and Market Size
The global Oral Controlled Drug Delivery System market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Oral Controlled Drug Delivery System market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2015-2026.

Segment by Type, the Oral Controlled Drug Delivery System market is segmented into
Diffusion Controlled Release System
Dissolution Controlled Release System
Ion Exchange Resins Controlled Release
Hydro-dynamically Balanced Drug Delivery System
Osmotically Controlled Release System
Dissolution & Diffusion Controlled Release System

Segment by Application, the Oral Controlled Drug Delivery System market is segmented into
Hospitals
Clinics
Other

The Oral Controlled Drug Delivery System market is analysed and market size information is provided by regions (countries). Segment by Application, the Oral Controlled Drug Delivery System market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.

Competitive Landscape and Oral Controlled Drug Delivery System Market Share Analysis
Oral Controlled Drug Delivery System market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Oral Controlled Drug Delivery System business, the date to enter into the Oral Controlled Drug Delivery System market, Oral Controlled Drug Delivery System product introduction, recent developments, etc.

The major vendors covered:
AstraZeneca Plc.
Mylan N.V.
Sanofi
F. Hoffman-La-Roche Ltd.
Bristol-Myers Squibb Company
Sun Pharmaceuticals Industries Ltd
Abbott Laboratories
Merck & Co. Inc.
Novartis AG
Pfizer Inc.
Vectura Group plc.
GlaxoSmithKline plc.
Johnson & Johnson Services, Inc.

レポート目次

1 Oral Controlled Drug Delivery System Market Overview
1.1 Oral Controlled Drug Delivery System Product Scope
1.2 Oral Controlled Drug Delivery System Segment by Type
1.2.1 Global Oral Controlled Drug Delivery System Sales by Type (2020-2026)
1.2.2 Diffusion Controlled Release System
1.2.3 Dissolution Controlled Release System
1.2.4 Ion Exchange Resins Controlled Release
1.2.5 Hydro-dynamically Balanced Drug Delivery System
1.2.6 Osmotically Controlled Release System
1.2.7 Dissolution & Diffusion Controlled Release System
1.3 Oral Controlled Drug Delivery System Segment by Application
1.3.1 Global Oral Controlled Drug Delivery System Sales Comparison by Application (2020-2026)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Other
1.4 Oral Controlled Drug Delivery System Market Estimates and Forecasts (2015-2026)
1.4.1 Global Oral Controlled Drug Delivery System Sales Growth Rate (2015-2026)
1.4.2 Global Oral Controlled Drug Delivery System Revenue and Growth Rate (2015-2026)
1.4.3 Global Oral Controlled Drug Delivery System Price Trends (2015-2026)

2 Oral Controlled Drug Delivery System Estimate and Forecast by Region
2.1 Global Oral Controlled Drug Delivery System Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Oral Controlled Drug Delivery System Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Oral Controlled Drug Delivery System Sales Market Share by Region (2015-2020)
2.2.2 Global Oral Controlled Drug Delivery System Revenue Market Share by Region (2015-2020)
2.3 Global Oral Controlled Drug Delivery System Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Oral Controlled Drug Delivery System Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Oral Controlled Drug Delivery System Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Oral Controlled Drug Delivery System Estimates and Projections (2015-2026)
2.4.2 Europe Oral Controlled Drug Delivery System Estimates and Projections (2015-2026)
2.4.3 China Oral Controlled Drug Delivery System Estimates and Projections (2015-2026)
2.4.4 Japan Oral Controlled Drug Delivery System Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Oral Controlled Drug Delivery System Estimates and Projections (2015-2026)
2.4.6 India Oral Controlled Drug Delivery System Estimates and Projections (2015-2026)
3 Global Oral Controlled Drug Delivery System Competition Landscape by Players
3.1 Global Top Oral Controlled Drug Delivery System Players by Sales (2015-2020)
3.2 Global Top Oral Controlled Drug Delivery System Players by Revenue (2015-2020)
3.3 Global Oral Controlled Drug Delivery System Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Oral Controlled Drug Delivery System as of 2019)
3.4 Global Oral Controlled Drug Delivery System Average Price by Company (2015-2020)
3.5 Manufacturers Oral Controlled Drug Delivery System Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Oral Controlled Drug Delivery System Players (Opinion Leaders)
4 Global Oral Controlled Drug Delivery System Market Size by Type
4.1 Global Oral Controlled Drug Delivery System Historic Market Review by Type (2015-2020)
4.1.1 Global Oral Controlled Drug Delivery System Sales Market Share by Type (2015-2020)
4.1.2 Global Oral Controlled Drug Delivery System Revenue Market Share by Type (2015-2020)
4.1.3 Global Oral Controlled Drug Delivery System Price by Type (2015-2020)
4.2 Global Oral Controlled Drug Delivery System Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Oral Controlled Drug Delivery System Sales Forecast by Type (2021-2026)
4.2.2 Global Oral Controlled Drug Delivery System Revenue Forecast by Type (2021-2026)
4.2.3 Global Oral Controlled Drug Delivery System Price Forecast by Type (2021-2026)
5 Global Oral Controlled Drug Delivery System Market Size by Application
5.1 Global Oral Controlled Drug Delivery System Historic Market Review by Application (2015-2020)
5.1.1 Global Oral Controlled Drug Delivery System Sales Market Share by Application (2015-2020)
5.1.2 Global Oral Controlled Drug Delivery System Revenue Market Share by Application (2015-2020)
5.1.3 Global Oral Controlled Drug Delivery System Price by Application (2015-2020)
5.2 Global Oral Controlled Drug Delivery System Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Oral Controlled Drug Delivery System Sales Forecast by Application (2021-2026)
5.2.2 Global Oral Controlled Drug Delivery System Revenue Forecast by Application (2021-2026)
5.2.3 Global Oral Controlled Drug Delivery System Price Forecast by Application (2021-2026)

6 United States Oral Controlled Drug Delivery System Market Facts & Figures
6.1 United States Oral Controlled Drug Delivery System Sales Market Share by Company (2015-2020)
6.2 United States Oral Controlled Drug Delivery System Sales Market Share by Type (2015-2020)
6.3 United States Oral Controlled Drug Delivery System Sales Market Share by Application (2015-2020)

7 Europe Oral Controlled Drug Delivery System Market Facts & Figures
7.1 Europe Oral Controlled Drug Delivery System Sales Market Share by Company (2015-2020)
7.2 Europe Oral Controlled Drug Delivery System Sales Market Share by Type (2015-2020)
7.3 Europe Oral Controlled Drug Delivery System Sales Market Share by Application (2015-2020)

8 China Oral Controlled Drug Delivery System Market Facts & Figures
8.1 China Oral Controlled Drug Delivery System Sales Market Share by Company (2015-2020)
8.2 China Oral Controlled Drug Delivery System Sales Market Share by Type (2015-2020)
8.3 China Oral Controlled Drug Delivery System Sales Market Share by Application (2015-2020)

9 Japan Oral Controlled Drug Delivery System Market Facts & Figures
9.1 Japan Oral Controlled Drug Delivery System Sales Market Share by Company (3015-3030)
9.2 Japan Oral Controlled Drug Delivery System Sales Market Share by Type (2015-2020)
9.3 Japan Oral Controlled Drug Delivery System Sales Market Share by Application (2015-2020)

10 Southeast Asia Oral Controlled Drug Delivery System Market Facts & Figures
10.1 Southeast Asia Oral Controlled Drug Delivery System Sales Market Share by Company (2015-2020)
10.2 Southeast Asia Oral Controlled Drug Delivery System Sales Market Share by Type (2015-2020)
10.3 Southeast Asia Oral Controlled Drug Delivery System Sales Market Share by Application (2015-2020)

11 India Oral Controlled Drug Delivery System Market Facts & Figures
11.1 India Oral Controlled Drug Delivery System Sales Market Share by Company (2015-2020)
11.2 India Oral Controlled Drug Delivery System Sales Market Share by Type (2015-2020)
11.3 India Oral Controlled Drug Delivery System Sales Market Share by Application (2015-2020)

12 Company Profiles and Key Figures in Oral Controlled Drug Delivery System Business
12.1 AstraZeneca Plc.
12.1.1 AstraZeneca Plc. Corporation Information
12.1.2 AstraZeneca Plc. Business Overview
12.1.3 AstraZeneca Plc. Oral Controlled Drug Delivery System Sales, Revenue and Gross Margin (2015-2020)
12.1.4 AstraZeneca Plc. Oral Controlled Drug Delivery System Products Offered
12.1.5 AstraZeneca Plc. Recent Development
12.2 Mylan N.V.
12.2.1 Mylan N.V. Corporation Information
12.2.2 Mylan N.V. Business Overview
12.2.3 Mylan N.V. Oral Controlled Drug Delivery System Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Mylan N.V. Oral Controlled Drug Delivery System Products Offered
12.2.5 Mylan N.V. Recent Development
12.3 Sanofi
12.3.1 Sanofi Corporation Information
12.3.2 Sanofi Business Overview
12.3.3 Sanofi Oral Controlled Drug Delivery System Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Sanofi Oral Controlled Drug Delivery System Products Offered
12.3.5 Sanofi Recent Development
12.4 F. Hoffman-La-Roche Ltd.
12.4.1 F. Hoffman-La-Roche Ltd. Corporation Information
12.4.2 F. Hoffman-La-Roche Ltd. Business Overview
12.4.3 F. Hoffman-La-Roche Ltd. Oral Controlled Drug Delivery System Sales, Revenue and Gross Margin (2015-2020)
12.4.4 F. Hoffman-La-Roche Ltd. Oral Controlled Drug Delivery System Products Offered
12.4.5 F. Hoffman-La-Roche Ltd. Recent Development
12.5 Bristol-Myers Squibb Company
12.5.1 Bristol-Myers Squibb Company Corporation Information
12.5.2 Bristol-Myers Squibb Company Business Overview
12.5.3 Bristol-Myers Squibb Company Oral Controlled Drug Delivery System Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Bristol-Myers Squibb Company Oral Controlled Drug Delivery System Products Offered
12.5.5 Bristol-Myers Squibb Company Recent Development
12.6 Sun Pharmaceuticals Industries Ltd
12.6.1 Sun Pharmaceuticals Industries Ltd Corporation Information
12.6.2 Sun Pharmaceuticals Industries Ltd Business Overview
12.6.3 Sun Pharmaceuticals Industries Ltd Oral Controlled Drug Delivery System Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Sun Pharmaceuticals Industries Ltd Oral Controlled Drug Delivery System Products Offered
12.6.5 Sun Pharmaceuticals Industries Ltd Recent Development
12.7 Abbott Laboratories
12.7.1 Abbott Laboratories Corporation Information
12.7.2 Abbott Laboratories Business Overview
12.7.3 Abbott Laboratories Oral Controlled Drug Delivery System Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Abbott Laboratories Oral Controlled Drug Delivery System Products Offered
12.7.5 Abbott Laboratories Recent Development
12.8 Merck & Co. Inc.
12.8.1 Merck & Co. Inc. Corporation Information
12.8.2 Merck & Co. Inc. Business Overview
12.8.3 Merck & Co. Inc. Oral Controlled Drug Delivery System Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Merck & Co. Inc. Oral Controlled Drug Delivery System Products Offered
12.8.5 Merck & Co. Inc. Recent Development
12.9 Novartis AG
12.9.1 Novartis AG Corporation Information
12.9.2 Novartis AG Business Overview
12.9.3 Novartis AG Oral Controlled Drug Delivery System Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Novartis AG Oral Controlled Drug Delivery System Products Offered
12.9.5 Novartis AG Recent Development
12.10 Pfizer Inc.
12.10.1 Pfizer Inc. Corporation Information
12.10.2 Pfizer Inc. Business Overview
12.10.3 Pfizer Inc. Oral Controlled Drug Delivery System Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Pfizer Inc. Oral Controlled Drug Delivery System Products Offered
12.10.5 Pfizer Inc. Recent Development
12.11 Vectura Group plc.
12.11.1 Vectura Group plc. Corporation Information
12.11.2 Vectura Group plc. Business Overview
12.11.3 Vectura Group plc. Oral Controlled Drug Delivery System Sales, Revenue and Gross Margin (2015-2020)
12.11.4 Vectura Group plc. Oral Controlled Drug Delivery System Products Offered
12.11.5 Vectura Group plc. Recent Development
12.12 GlaxoSmithKline plc.
12.12.1 GlaxoSmithKline plc. Corporation Information
12.12.2 GlaxoSmithKline plc. Business Overview
12.12.3 GlaxoSmithKline plc. Oral Controlled Drug Delivery System Sales, Revenue and Gross Margin (2015-2020)
12.12.4 GlaxoSmithKline plc. Oral Controlled Drug Delivery System Products Offered
12.12.5 GlaxoSmithKline plc. Recent Development
12.13 Johnson & Johnson Services, Inc.
12.13.1 Johnson & Johnson Services, Inc. Corporation Information
12.13.2 Johnson & Johnson Services, Inc. Business Overview
12.13.3 Johnson & Johnson Services, Inc. Oral Controlled Drug Delivery System Sales, Revenue and Gross Margin (2015-2020)
12.13.4 Johnson & Johnson Services, Inc. Oral Controlled Drug Delivery System Products Offered
12.13.5 Johnson & Johnson Services, Inc. Recent Development

13 Oral Controlled Drug Delivery System Manufacturing Cost Analysis
13.1 Oral Controlled Drug Delivery System Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Oral Controlled Drug Delivery System
13.4 Oral Controlled Drug Delivery System Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Oral Controlled Drug Delivery System Distributors List
14.3 Oral Controlled Drug Delivery System Customers

15 Market Dynamics
15.1 Oral Controlled Drug Delivery System Market Trends
15.2 Oral Controlled Drug Delivery System Opportunities and Drivers
15.3 Oral Controlled Drug Delivery System Market Challenges
15.4 Oral Controlled Drug Delivery System Market Restraints
15.5 Porter’s Five Forces Analysis

16 Research Findings and Conclusion

17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer

List of Tables
Table 1. Global Oral Controlled Drug Delivery System Sales (K Units) Growth Rate by Type (2020-2026) (US$ Million)
Table 2. Global Oral Controlled Drug Delivery System Sales (K Units) Comparison by Application (2020-2026) (US$ Million)
Table 3. Global Market Oral Controlled Drug Delivery System Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 4. Global Oral Controlled Drug Delivery System Sales (K Units) by Region (2015-2020)
Table 5. Global Oral Controlled Drug Delivery System Sales Market Share by Region (2015-2020)
Table 6. Global Oral Controlled Drug Delivery System Revenue (US$ Million) Market Share by Region (2015-2020))
Table 7. Global Oral Controlled Drug Delivery System Revenue Share by Region (2015-2020)
Table 8. Global Oral Controlled Drug Delivery System Sales (K Units) Forecast by Region (2021-2026)
Table 9. Global Oral Controlled Drug Delivery System Sales Market Share Forecast by Region (2021-2026)
Table 10. Global Oral Controlled Drug Delivery System Revenue (US$ Million) Forecast by Region (2021-2026)
Table 11. Global Oral Controlled Drug Delivery System Revenue Share Forecast by Region (2021-2026)
Table 12. Global Oral Controlled Drug Delivery System (K Units) of Key Companies (2015-2020)
Table 13. Global Oral Controlled Drug Delivery System Sales Share by Company (2015-2020)
Table 14. Global Oral Controlled Drug Delivery System Revenue (US$ Million) by Company (2015-2020)
Table 15. Global Oral Controlled Drug Delivery System Revenue Share by Company (2015-2020)
Table 16. Global Oral Controlled Drug Delivery System by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Oral Controlled Drug Delivery System as of 2019)
Table 17. Global Oral Controlled Drug Delivery System Average Price (USD/Unit) of Key Company (2015-2020)
Table 18. Manufacturers Oral Controlled Drug Delivery System Manufacturing Sites and Area Served
Table 19. Manufacturers Oral Controlled Drug Delivery System Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Main Points Interviewed from Key Oral Controlled Drug Delivery System Players
Table 22. Global Oral Controlled Drug Delivery System Sales (K Units) by Type (2015-2020)
Table 23. Global Oral Controlled Drug Delivery System Sales Share by Type (2015-2020)
Table 24. Global Oral Controlled Drug Delivery System Revenue (US$ Million) Market Share by Type (2015-2020)
Table 25. Global Oral Controlled Drug Delivery System Price (K Units) by Type (2015-2020)
Table 26. Global Oral Controlled Drug Delivery System Sales Share by Type (2021-2026)
Table 27. Global Oral Controlled Drug Delivery System Revenue (US$ Million) Market Share by Type (2021-2026)
Table 28. Global Oral Controlled Drug Delivery System Revenue Share by Type (2021-2026)
Table 29. Global Oral Controlled Drug Delivery System Price (K Units) by Type (2021-2026)
Table 30. Global Oral Controlled Drug Delivery System Sales (K Units) by Application (2015-2020)
Table 31. Global Oral Controlled Drug Delivery System Sales Share by Application (2015-2020)
Table 32. Global Oral Controlled Drug Delivery System Revenue (US$ Million) Market Share by Application (2015-2020)
Table 33. Global Oral Controlled Drug Delivery System Price (K Units) by Application (2015-2020)
Table 34. Global Oral Controlled Drug Delivery System Sales (K Units) by Application (2021-2026)
Table 35. Global Oral Controlled Drug Delivery System Sales Share by Application (2021-2026)
Table 36. Global Oral Controlled Drug Delivery System Revenue (US$ Million) Market Share by Application (2021-2026)
Table 37. Global Oral Controlled Drug Delivery System Revenue Share by Application (2021-2026)
Table 38. Global Oral Controlled Drug Delivery System Price (K Units) by Application (2021-2026)
Table 39. United States Oral Controlled Drug Delivery System Sales (K Units) by Company (2015-2020)
Table 40. United States Oral Controlled Drug Delivery System Sales Market Share by Company (2015-2020)
Table 41. United States Oral Controlled Drug Delivery System Sales (K Units) by Type (2015-2020)
Table 42. United States Oral Controlled Drug Delivery System Sales Market Share by Type (2015-2020)
Table 43. United States Oral Controlled Drug Delivery System Sales (K Units) by Application (2015-2020)
Table 44. United States Oral Controlled Drug Delivery System Sales Market Share by Application (2015-2020)
Table 45. Europe Oral Controlled Drug Delivery System Sales (K Units) by Company (2015-2020)
Table 46. Europe Oral Controlled Drug Delivery System Sales Market Share by Company (2015-2020)
Table 47. Europe Oral Controlled Drug Delivery System Sales (K Units) by Type (2015-2020)
Table 48. Europe Oral Controlled Drug Delivery System Sales Market Share by Type (2015-2020)
Table 49. Europe Oral Controlled Drug Delivery System Sales (K Units) by Application (2015-2020)
Table 50. Europe Oral Controlled Drug Delivery System Sales Market Share by Type (2015-2020)
Table 51. China Oral Controlled Drug Delivery System Sales (K Units) by Company (2015-2020)
Table 52. China Oral Controlled Drug Delivery System Sales Market Share by Company (2015-2020)
Table 53. China Oral Controlled Drug Delivery System Sales (K Units) by Type (2015-2020)
Table 54. China Oral Controlled Drug Delivery System Sales Market Share by Type (2015-2020)
Table 55. China Oral Controlled Drug Delivery System Sales (K Units) by Application (2015-2020)
Table 56. China Oral Controlled Drug Delivery System Sales Market Share by Application (2015-2020)
Table 57. Japan Oral Controlled Drug Delivery System Sales (K Units) by Company (2015-2020)
Table 58. Japan Oral Controlled Drug Delivery System Sales Market Share by Company (2015-2020)
Table 59. Japan Oral Controlled Drug Delivery System Sales (K Units) by Type (2015-2020)
Table 60. Japan Oral Controlled Drug Delivery System Sales Market Share by Type (2015-2020)
Table 61. Japan Oral Controlled Drug Delivery System Sales (K Units) by Application (2015-2020)
Table 62. Japan Oral Controlled Drug Delivery System Sales Market Share by Application (2015-2020)
Table 63. Southeast Asia Oral Controlled Drug Delivery System Sales (K Units) by Company (2015-2020)
Table 64. Southeast Asia Oral Controlled Drug Delivery System Sales Market Share by Company (2015-2020)
Table 65. Southeast Asia Oral Controlled Drug Delivery System Sales (K Units) by Type (2015-2020)
Table 66. Southeast Asia Oral Controlled Drug Delivery System Sales Market Share by Type (2015-2020)
Table 67. Southeast Asia Oral Controlled Drug Delivery System Sales (K Units) by Type (2015-2020)
Table 68. Southeast Asia Oral Controlled Drug Delivery System Sales Market Share by Application (2015-2020)
Table 69. India Oral Controlled Drug Delivery System Sales (K Units) by Company (2015-2020)
Table 70. India Oral Controlled Drug Delivery System Sales Market Share by Company (2015-2020)
Table 71. India Oral Controlled Drug Delivery System Sales (K Units) by Type (2015-2020)
Table 72. India Oral Controlled Drug Delivery System Sales Market Share by Type (2015-2020)
Table 73. India Oral Controlled Drug Delivery System Sales (K Units) by Application (2015-2020)
Table 74. India Oral Controlled Drug Delivery System Sales Market Share by Application (2015-2020)
Table 75. AstraZeneca Plc. Corporation Information
Table 76. AstraZeneca Plc. Description and Business Overview
Table 77. AstraZeneca Plc. Oral Controlled Drug Delivery System Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 78. AstraZeneca Plc. Oral Controlled Drug Delivery System Product
Table 79. AstraZeneca Plc. Recent Development
Table 80. Mylan N.V. Corporation Information
Table 81. Mylan N.V. Description and Business Overview
Table 82. Mylan N.V. Oral Controlled Drug Delivery System Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 83. Mylan N.V. Oral Controlled Drug Delivery System Product
Table 84. Mylan N.V. Recent Development
Table 85. Sanofi Corporation Information
Table 86. Sanofi Description and Business Overview
Table 87. Sanofi Oral Controlled Drug Delivery System Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 88. Sanofi Oral Controlled Drug Delivery System Product
Table 89. Sanofi Recent Development
Table 90. F. Hoffman-La-Roche Ltd. Corporation Information
Table 91. F. Hoffman-La-Roche Ltd. Description and Business Overview
Table 92. F. Hoffman-La-Roche Ltd. Oral Controlled Drug Delivery System Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 93. F. Hoffman-La-Roche Ltd. Oral Controlled Drug Delivery System Product
Table 94. F. Hoffman-La-Roche Ltd. Recent Development
Table 95. Bristol-Myers Squibb Company Corporation Information
Table 96. Bristol-Myers Squibb Company Description and Business Overview
Table 97. Bristol-Myers Squibb Company Oral Controlled Drug Delivery System Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 98. Bristol-Myers Squibb Company Oral Controlled Drug Delivery System Product
Table 99. Bristol-Myers Squibb Company Recent Development
Table 100. Sun Pharmaceuticals Industries Ltd Corporation Information
Table 101. Sun Pharmaceuticals Industries Ltd Description and Business Overview
Table 102. Sun Pharmaceuticals Industries Ltd Oral Controlled Drug Delivery System Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 103. Sun Pharmaceuticals Industries Ltd Oral Controlled Drug Delivery System Product
Table 104. Sun Pharmaceuticals Industries Ltd Recent Development
Table 105. Abbott Laboratories Corporation Information
Table 106. Abbott Laboratories Description and Business Overview
Table 107. Abbott Laboratories Oral Controlled Drug Delivery System Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 108. Abbott Laboratories Oral Controlled Drug Delivery System Product
Table 109. Abbott Laboratories Recent Development
Table 110. Merck & Co. Inc. Corporation Information
Table 111. Merck & Co. Inc. Oral Controlled Drug Delivery System Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 112. Merck & Co. Inc. Description and Business Overview
Table 113. Merck & Co. Inc. Oral Controlled Drug Delivery System Product
Table 114. Merck & Co. Inc. Recent Development
Table 115. Novartis AG Corporation Information
Table 116. Novartis AG Oral Controlled Drug Delivery System Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 117. Novartis AG Description and Business Overview
Table 118. Novartis AG Oral Controlled Drug Delivery System Product
Table 119. Novartis AG Recent Development
Table 120. Pfizer Inc. Corporation Information
Table 121. Pfizer Inc. Description and Business Overview
Table 122. Pfizer Inc. Oral Controlled Drug Delivery System Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 123. Pfizer Inc. Oral Controlled Drug Delivery System Product
Table 124. Pfizer Inc. Recent Development
Table 125. Vectura Group plc. Corporation Information
Table 126. Vectura Group plc. Description and Business Overview
Table 127. Vectura Group plc. Oral Controlled Drug Delivery System Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 128. Vectura Group plc. Oral Controlled Drug Delivery System Product
Table 129. Vectura Group plc. Recent Development
Table 130. GlaxoSmithKline plc. Corporation Information
Table 131. GlaxoSmithKline plc. Description and Business Overview
Table 132. GlaxoSmithKline plc. Oral Controlled Drug Delivery System Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 133. GlaxoSmithKline plc. Oral Controlled Drug Delivery System Product
Table 134. GlaxoSmithKline plc. Recent Development
Table 135. Johnson & Johnson Services, Inc. Corporation Information
Table 136. Johnson & Johnson Services, Inc. Description and Business Overview
Table 137. Johnson & Johnson Services, Inc. Oral Controlled Drug Delivery System Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 138. Johnson & Johnson Services, Inc. Oral Controlled Drug Delivery System Product
Table 139. Johnson & Johnson Services, Inc. Recent Development
Table 140. Production Base and Market Concentration Rate of Raw Material
Table 141. Key Suppliers of Raw Materials
Table 142. Oral Controlled Drug Delivery System Distributors List
Table 143. Oral Controlled Drug Delivery System Customers List
Table 144. Oral Controlled Drug Delivery System Market Key Trends
Table 145. Oral Controlled Drug Delivery System Key Opportunities and Drivers
Table 146. Oral Controlled Drug Delivery System Market Challenges
Table 147. Research Programs/Design for This Report
Table 148. Key Data Information from Secondary Sources
Table 149. Key Data Information from Primary Sources
List of Figures
Figure 1. Oral Controlled Drug Delivery System Product Picture
Figure 2. Global Oral Controlled Drug Delivery System Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Oral Controlled Drug Delivery System Market Share by Application in 2020 & 2026
Figure 6. Hospitals Examples
Figure 7. Clinics Examples
Figure 8. Other Examples
Figure 9. Global Oral Controlled Drug Delivery System Sales (K Units) Growth Rate (2015-2026)
Figure 10. Global Oral Controlled Drug Delivery System Revenue (US$ Million) Growth Rate (2015-2026)
Figure 11. Global Oral Controlled Drug Delivery System Price Trends Growth Rate (2015-2026) (USD/Unit)
Figure 12. Global Oral Controlled Drug Delivery System Revenue Market Share by Region: 2015 VS 2020
Figure 13. Global Oral Controlled Drug Delivery System Revenue Market Share by Region: 2021 VS 2026
Figure 14. United States Oral Controlled Drug Delivery System Revenue (Million USD) Growth Rate (2015-2026)
Figure 15. United States Oral Controlled Drug Delivery System Sales (K Units) Growth Rate (2015-2026)
Figure 16. Europe Oral Controlled Drug Delivery System Revenue (Million USD) Growth Rate (2015-2026)
Figure 17. Europe Oral Controlled Drug Delivery System Sales (Million USD) Growth Rate (2015-2026)
Figure 18. China Oral Controlled Drug Delivery System Revenue (Million USD) Growth Rate (2015-2026)
Figure 19. China Oral Controlled Drug Delivery System Sales (Million USD) and Growth Rate (2015-2026)
Figure 20. Japan Oral Controlled Drug Delivery System Revenue (Million USD) Growth Rate (2015-2026)
Figure 21. Japan Oral Controlled Drug Delivery System Sales (Million USD) Growth Rate (2015-2026)
Figure 22. Southeast Asia Oral Controlled Drug Delivery System Revenue (Million USD) Growth Rate (2015-2026)
Figure 23. Southeast Asia Oral Controlled Drug Delivery System Sales (Million USD) Growth Rate (2015-2026)
Figure 24. India Oral Controlled Drug Delivery System Revenue (Million USD) Growth Rate (2015-2026)
Figure 25. India Oral Controlled Drug Delivery System Sales (Million USD) Growth Rate (2015-2026)
Figure 26. Global 5 Largest Oral Controlled Drug Delivery System Players Market Share by Revenue in Oral Controlled Drug Delivery System 2015 & 2019
Figure 27. Oral Controlled Drug Delivery System Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 28. Global Oral Controlled Drug Delivery System Revenue Share by Type (2015-2020)
Figure 29. Global Oral Controlled Drug Delivery System Revenue Growth Rate by Type in 2015 & 2019
Figure 30. Global Oral Controlled Drug Delivery System Revenue Share by Application (2015-2020)
Figure 31. Global Oral Controlled Drug Delivery System Revenue Growth Rate by Application in 2015 & 2019
Figure 32. United States Oral Controlled Drug Delivery System Sales Market Share by Type in 2019
Figure 33. United States Oral Controlled Drug Delivery System Sales Market Share by Type in 2019
Figure 34. Europe Oral Controlled Drug Delivery System Sales Market Share by Company in 2019
Figure 35. Europe Oral Controlled Drug Delivery System Sales Market Share by Type in 2019
Figure 36. Europe Oral Controlled Drug Delivery System Sales Market Share by Application in 2019
Figure 37. China Oral Controlled Drug Delivery System Sales Market Share by Company in 2019
Figure 38. China Oral Controlled Drug Delivery System Sales Market Share by Type in 2019
Figure 39. China Oral Controlled Drug Delivery System Sales Market Share by Application in 2019
Figure 40. Japan Oral Controlled Drug Delivery System Sales Market Share by Company in 2019
Figure 41. Japan Oral Controlled Drug Delivery System Sales Market Share by Type in 2019
Figure 42. Japan Oral Controlled Drug Delivery System Sales Market Share by Application in 2019
Figure 43. Southeast Asia Oral Controlled Drug Delivery System Sales Market Share by Company in 2019
Figure 44. Southeast Asia Oral Controlled Drug Delivery System Sales Market Share by Type in 2019
Figure 45. Southeast Asia Oral Controlled Drug Delivery System Sales Market Share by Application in 2019
Figure 46. India Oral Controlled Drug Delivery System Sales Market Share by Company in 2019
Figure 47. India Oral Controlled Drug Delivery System Sales Market Share by Type in 2019
Figure 48. India Oral Controlled Drug Delivery System Sales Market Share by Application in 2019
Figure 49. Key Raw Materials Price Trend
Figure 50. Manufacturing Cost Structure of Oral Controlled Drug Delivery System
Figure 51. Manufacturing Process Analysis of Oral Controlled Drug Delivery System
Figure 52. Oral Controlled Drug Delivery System Industrial Chain Analysis
Figure 53. Channels of Distribution
Figure 54. Distributors Profiles
Figure 55. Porter's Five Forces Analysis
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed